Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&lookfor=%22Case+Reports%22&type=Subject&page=2
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&lookfor=%22Case+Reports%22&type=Subject&page=2
Search /vufind/Search2/Results?filter%5B%5D=collection%3A%22CTG%22&lookfor=%22Case+Reports%22&type=Subject&page=2
PubPharm (23)
11
The effect of calcium and vitamin D on the heartmusclef unction - Heartmuscle function and vitamin D : The effect of calcium and vitamin D on the heartmusclef unction - Heartmuscle function and vitamin D
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
12
Intraocular use of Lucentis (Ranibizumab) in the treatment of acute central serous chorioretinopathy, an inflammatory diesease of the retina. : Intravitreal Lucentis (Ranibizumab) in acute central serous Chrioretinopathy - a prospective, randomized, single blind monocentric study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
13
Intraocular use of Lucentis (Ranibizumab) in the treatment of acute central serous chorioretinopathy, an inflammatory diesease of the retina. : Intravitreal Lucentis (Ranibizumab) in acute central serous Chrioretinopathy - a prospective, randomized, single blind monocentric study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
14
Safety and tolerability of the Japanese encephalitis vaccine IC51 (JE-PIV). Double blind, randomized, placebo controlled phase 3 study - IC51- 302 : Safety and tolerability of the Japanese encephalitis vaccine IC51 (JE-PIV). Double blind, randomized, placebo controlled phase 3 study - IC51- 302
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
15
Safety and tolerability of the Japanese encephalitis vaccine IC51 (JE-PIV). Double blind, randomized, placebo controlled phase 3 study - IC51- 302 : Safety and tolerability of the Japanese encephalitis vaccine IC51 (JE-PIV). Double blind, randomized, placebo controlled phase 3 study - IC51- 302
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
16
Evaluation of growth response in short children suffering from a disease with growth retardation and treated with Somatropin: A prospective, longitudinal non-randomised, open, phase II study : Evaluation of growth response in short children suffering from a disease with growth retardation and treated with Somatropin: A prospective, longitudinal non-randomised, open, phase II study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2014
Wird geladen...
17
Evaluation of growth response in short children suffering from a disease with growth retardation and treated with Somatropin: A prospective, longitudinal non-randomised, open, phase II study : Evaluation of growth response in short children suffering from a disease with growth retardation and treated with Somatropin: A prospective, longitudinal non-randomised, open, phase II study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2014
Wird geladen...
18
Safety and tolerability of the Japanese encephalitis vaccine IC51 (JE-PIV). Double blind, randomized, placebo controlled phase 3 study - IC51- 302 : Safety and tolerability of the Japanese encephalitis vaccine IC51 (JE-PIV). Double blind, randomized, placebo controlled phase 3 study - IC51- 302
enthalten in:
WHO International Clinical Trials Registry Platform
| 2013
Wird geladen...
19
Observer blinded, randomized Phase III study to investigate the non-inferiority of IC51 (JE-PIV) vs. JE-VAX as vaccines for japanese encephalitis in healthy volunteers - IC51-301 : Observer blinded, randomized Phase III study to investigate the non-inferiority of IC51 (JE-PIV) vs. JE-VAX as vaccines for japanese encephalitis in healthy volunteers - IC51-301
enthalten in:
WHO International Clinical Trials Registry Platform
| 2013
Wird geladen...
20
Safety and tolerability of the Japanese encephalitis vaccine IC51 (JE-PIV). Double blind, randomized, placebo controlled phase 3 study - IC51- 302 : Safety and tolerability of the Japanese encephalitis vaccine IC51 (JE-PIV). Double blind, randomized, placebo controlled phase 3 study - IC51- 302
enthalten in:
WHO International Clinical Trials Registry Platform
| 2013
Wird geladen...
[1]
« Vorheriger
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
23
Aufsätze
23
E-Artikel
23
E-Ressourcen
Zeitschriftentitel
22
WHO International Clinical Trials Registry Plat...
1
ClinicalTrials.gov
Thema
23
610
18
Study Type: Interventional
14
Recruitment Status: Not yet recruiting
8
Medical Condition: Japanese encephalitis (JE) i...
4
Recruitment Status: Completed
4
Recruitment Status: Recruiting
3
Study Type: Observational
2
Medical Condition: Acute central serous chorior...
2
Medical Condition: Case report
2
Medical Condition: Effect of intervention with ...
2
Medical Condition: Genotropin®) is approved fo...
2
Medical Condition: Health Condition 1: null- Al...
2
Medical Condition: Pulmonary function and respi...
2
Medical Condition: Tinnitus is a symptom define...
2
Phase: Phase 1/Phase 2
2
Phase: Phase 2
2
Phase: Phase 3
2
Phase: Phase 4
2
Study Type: Others,meta-analysis etc
1
Medical Condition: Case Report Form, Declaratio...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
13
2020-
10
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
23
Englisch
Haven't found what you're looking for?
Wird geladen...